JP2014530192A5 - - Google Patents

Download PDF

Info

Publication number
JP2014530192A5
JP2014530192A5 JP2014530805A JP2014530805A JP2014530192A5 JP 2014530192 A5 JP2014530192 A5 JP 2014530192A5 JP 2014530805 A JP2014530805 A JP 2014530805A JP 2014530805 A JP2014530805 A JP 2014530805A JP 2014530192 A5 JP2014530192 A5 JP 2014530192A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
composition
composition according
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014530805A
Other languages
English (en)
Japanese (ja)
Other versions
JP6038155B2 (ja
JP2014530192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/055248 external-priority patent/WO2013040269A1/en
Publication of JP2014530192A publication Critical patent/JP2014530192A/ja
Publication of JP2014530192A5 publication Critical patent/JP2014530192A5/ja
Application granted granted Critical
Publication of JP6038155B2 publication Critical patent/JP6038155B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014530805A 2011-09-13 2012-09-13 組織創傷を治癒させる製品 Active JP6038155B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161534194P 2011-09-13 2011-09-13
US61/534,194 2011-09-13
PCT/US2012/055248 WO2013040269A1 (en) 2011-09-13 2012-09-13 Products for healing of tissue wounds

Publications (3)

Publication Number Publication Date
JP2014530192A JP2014530192A (ja) 2014-11-17
JP2014530192A5 true JP2014530192A5 (cg-RX-API-DMAC7.html) 2015-10-01
JP6038155B2 JP6038155B2 (ja) 2016-12-07

Family

ID=47071446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530805A Active JP6038155B2 (ja) 2011-09-13 2012-09-13 組織創傷を治癒させる製品

Country Status (12)

Country Link
US (1) US9161942B2 (cg-RX-API-DMAC7.html)
EP (1) EP2760454B1 (cg-RX-API-DMAC7.html)
JP (1) JP6038155B2 (cg-RX-API-DMAC7.html)
KR (1) KR101966293B1 (cg-RX-API-DMAC7.html)
CN (1) CN104080458B (cg-RX-API-DMAC7.html)
AU (2) AU2012308530B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014005914B1 (cg-RX-API-DMAC7.html)
CA (1) CA2848567C (cg-RX-API-DMAC7.html)
IL (1) IL231509B (cg-RX-API-DMAC7.html)
MX (1) MX369385B (cg-RX-API-DMAC7.html)
RU (1) RU2652308C2 (cg-RX-API-DMAC7.html)
WO (2) WO2013040265A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010036427A1 (en) 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
CN104053458B (zh) 2011-07-20 2016-07-20 布莱阿姆青年大学 包含洗脱塞拉集宁化合物的水凝胶材料
US8932614B2 (en) 2011-08-25 2015-01-13 Paul B. Savage Incorporation of particulate ceragenins in polymers
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
JP6038154B2 (ja) 2011-09-13 2016-12-07 ブリガム・ヤング・ユニバーシティBrigham Young University 骨疾患および破断骨治療のための組成物
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
BR112014015144B1 (pt) 2011-12-21 2018-03-27 Brigham Young University Composição aquosa para cuidado oral, uso de um composto esteroide catiônico e método não- terapêutico de redução de compostos voláteis de enxofre
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
CA2872399C (en) 2012-05-02 2021-01-12 Brigham Young University Ceragenin particulate materials and methods for making same
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
WO2014107740A2 (en) 2013-01-07 2014-07-10 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) * 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) * 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US20170174720A9 (en) * 2015-04-22 2017-06-22 Brigham Young University Cationic steroidal antimicrobial salts
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
CN108348484B (zh) * 2015-04-22 2021-12-17 布莱阿姆青年大学 阳离子甾体抗微生物盐
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9434759B1 (en) * 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US20170080128A1 (en) * 2015-09-21 2017-03-23 Brigham Young University Novel endotracheal tube for the reduction of intubation-related complication in neonates and babies
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
KR101792535B1 (ko) 2017-09-27 2017-11-02 오상자이엘 주식회사 화상 치료용 키트
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428800A (en) * 1890-05-27 miller
US4661341A (en) 1984-10-30 1987-04-28 The Procter & Gamble Company Oral compositions
US4842593A (en) 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US4865855A (en) 1988-01-11 1989-09-12 Kimberly-Clark Corporation Antimicrobial absorbent food pad
US4990338A (en) 1988-05-09 1991-02-05 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US4972848A (en) 1989-08-23 1990-11-27 Medtronic, Inc. Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5286479A (en) 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
DK0690864T3 (da) 1993-03-12 2001-09-17 Upjohn Co Krystallinsk ceftiofur på fri syreform
DK0749437T3 (da) * 1994-03-10 2002-03-04 Magainin Pharma Farmaceutisk anvendelse af steroidderivater
US6132765A (en) 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
JP2000515523A (ja) * 1996-07-22 2000-11-21 ザ・ビクトリア・ユニバーシティ・オブ・マンチェスター 創傷および線維性障害の治療における性ステロイド機能モジュレーターの使用
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
EP1058552B1 (en) 1998-03-06 2004-06-16 Brigham Young University Steroid derived antibiotics
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
EP1311531B1 (en) 2000-08-15 2016-05-11 Brigham Young University Steroid derived antibiotics
US6514556B2 (en) 2000-12-15 2003-02-04 Ecolab Inc. Method and composition for washing poultry during processing
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
AU2002324723B2 (en) 2001-08-16 2007-10-25 The Trustees Of The University Of Pennsylvania Synthesis and use of reagents for improved DNA lipofection and/or slow release pro-drug and drug therapies
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
DE10218147B4 (de) 2002-04-23 2005-12-22 Stockhausen Gmbh Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögernde Polymerteilchen, deren Herstellung und Verwendung
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7659061B2 (en) 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7282214B2 (en) 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
NZ543643A (en) 2003-06-23 2007-09-28 Beiersdorf Ag Antimicrobial wound dressing with two layers and antimicrobial metal between layers but not on exterior
GB0318901D0 (en) 2003-08-12 2003-09-17 Univ Bath Improvements in or relating to bone substitute material
US20050267051A1 (en) * 2003-12-19 2005-12-01 Lee Henry J Antineoplastic and anti-HIV conjugates of steroid acid and nucleosides
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20060062773A1 (en) 2004-09-21 2006-03-23 The Procter & Gamble Company Compositions for maintaining and restoring normal gastrointestinal flora
US7754705B2 (en) * 2006-02-01 2010-07-13 Brigham Young University Cationic steroid antimicrobial compositions and methods of use
US20070190067A1 (en) 2006-02-01 2007-08-16 Savage Paul B Cationic Steroid Antimicrobial Compositions and Methods of Use
US20070191322A1 (en) * 2006-02-01 2007-08-16 Savage Paul B Cationic Steroid Microbial Compositions and Methods of Use
WO2007089906A2 (en) * 2006-02-01 2007-08-09 Brigham Young University Cationic steroid antimicrobial compositions for treating or preventing herpes infections
WO2007134176A2 (en) 2006-05-10 2007-11-22 Microban Products Company Antimicrobial food pad
US7858000B2 (en) 2006-06-08 2010-12-28 Novartis Ag Method of making silicone hydrogel contact lenses
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
WO2008038965A1 (en) 2006-09-26 2008-04-03 Kyungpook National University Industry-Academic Cooperation Foundation 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
US7854941B2 (en) 2007-02-12 2010-12-21 The University Of Southern Mississippi Method of attaching drug compounds to non-reactive polymer surfaces
US20090016973A1 (en) 2007-07-09 2009-01-15 Micropure, Inc. Composition and Method for the Prevention of Oral Disease
US20090068122A1 (en) 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
US9095568B2 (en) 2007-09-26 2015-08-04 Mark Berninger Therapeutic and vaccine polyelectrolyte nanoparticle compositions
WO2010036427A1 (en) 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US20090324517A1 (en) 2008-06-30 2009-12-31 Dan Kline Halitosis treatment
WO2011006100A1 (en) * 2009-07-09 2011-01-13 Crescendo Therapeutics, Llc Method of wound healing and scar modulation
WO2011066260A2 (en) 2009-11-25 2011-06-03 Michael Zasloff Formulations comprising aminosterols
US8557031B1 (en) * 2010-01-07 2013-10-15 Sandia Corporation Methods for attaching polymerizable ceragenins to water treatment membranes using amine and amide linkages
AU2011222612A1 (en) * 2010-03-04 2012-09-20 The Trustees Of The University Of Pennsylvania Center For Technology Transfer Antimicrobial cationic stereoids and methods of use
US8871716B2 (en) * 2010-10-08 2014-10-28 Korea Advanced Institute Of Science And Technology Use of antimicrobial peptides in regeneration of skin cells
CN103313597B (zh) 2010-11-03 2016-06-29 布莱阿姆青年大学 结合吸水性聚合物和塞拉集宁化合物的制品
CN102172356B (zh) * 2011-03-03 2013-04-03 山东农业大学 牛磺鹅去氧胆酸在制备防治骨质疏松的药物中的应用
US8810380B2 (en) 2011-07-01 2014-08-19 Gerald F. Leitz Golf scoring management system
CN104053458B (zh) 2011-07-20 2016-07-20 布莱阿姆青年大学 包含洗脱塞拉集宁化合物的水凝胶材料
WO2013029055A1 (en) 2011-08-25 2013-02-28 Brigham Young University Incorporation of particulate ceragenins in polymers
US8932614B2 (en) 2011-08-25 2015-01-13 Paul B. Savage Incorporation of particulate ceragenins in polymers
WO2013029059A1 (en) 2011-08-25 2013-02-28 Brigham Young University Medical devices incorporating ceragenin-containing composites
BR112014015144B1 (pt) 2011-12-21 2018-03-27 Brigham Young University Composição aquosa para cuidado oral, uso de um composto esteroide catiônico e método não- terapêutico de redução de compostos voláteis de enxofre
EP2819531B1 (en) 2012-03-01 2016-01-20 Brigham Young University Anti-microbial food processing compositions including ceragenin compounds and methods of use
US20130280391A1 (en) 2012-04-24 2013-10-24 Brigham Young University Anti-microbial wash compositions including ceragenin compounds and methods of use for treating non-meat food products
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
WO2014107740A2 (en) 2013-01-07 2014-07-10 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods

Similar Documents

Publication Publication Date Title
JP2014530192A5 (cg-RX-API-DMAC7.html)
JP2014530191A5 (cg-RX-API-DMAC7.html)
RU2014112784A (ru) Способы и продукты для заживления ран тканей
JP7189983B2 (ja) 異常炎症反応に関連する状態を処置するための方法および組成物
US11992554B2 (en) Polyfunctional radical scavenger hydrogel formulation
KR20240039083A (ko) 약제학적 제형
RU2015133450A (ru) Соединения имидазопиридина и их применение
ES2964341T3 (es) Composición adhesiva
RU2011136250A (ru) Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
WO2009063202A3 (en) Use of crth2 antagonist compounds
HRP20171805T1 (hr) Derivati 17-hidroksi-17-pentafluoroetil-estra-4,9(10)-dien-11-arila, postupci za njihovu proizvodnju i njihova upotreba za liječenje bolesti
JP2011521969A5 (cg-RX-API-DMAC7.html)
AR059425A1 (es) Amidas ciclicas condensadas del acido bencensulfonico, un metodo para su preparacion, composiciones farmaceuticas que las contienen y el empleo de las mismas en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de l-cpt1
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
MX2013001929A (es) Nuevos compuestos
RU2016143751A (ru) Фармацевтическая композиция
RU2013121788A (ru) Ингибиторы репликации вич
JP2013507487A (ja) 接着剤組成物
JP2017517565A5 (cg-RX-API-DMAC7.html)
BR112014030099A2 (pt) combinação de um inibidor 17-alfa-hidroxilase(c17,20-liase) e um inibidor pi-3 k específico para tratamento de uma doença de tumor
NO20092539L (no) Antibakterielle kinolin-derivater
JP2009544665A5 (cg-RX-API-DMAC7.html)
RU2011126113A (ru) Композиция для борьбы с болезнями растений и способ борьбы с болезнями растений
JP2011512362A5 (cg-RX-API-DMAC7.html)
RU2013123362A (ru) Применение стабильных при хранении вязких депофосфолипидов для лечения ран